Journal
ARTHRITIS RESEARCH & THERAPY
Volume 11, Issue 2, Pages -Publisher
BIOMED CENTRAL LTD
DOI: 10.1186/ar2642
Keywords
-
Categories
Funding
- FWO Vlaanderen
- KU Leuven
Ask authors/readers for more resources
Targeted therapies that neutralize tumour necrosis factor are often able to control the signs and symptoms of spondyloarthritis. However, recent animal model data and clinical observations indicate that control of inflammation may not be sufficient to impede disease progression toward ankylosis in these patients. Bone morphogenetic proteins and WNTs (wingless-type like) are likely to play an important role in ankylosis and could be therapeutic targets. The relationship between inflammation and new bone formation is still unclear. This review summarizes progress made in our understanding of ankylosis and offers an alternative view of the relationship between inflammation and ankylosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available